Filter
802
Text search:
Multidrug
resistant
tuberculosis
Featured
95
189
Language
Document type
489
124
96
33
22
19
7
7
3
1
1
Countries / Regions
52
37
30
21
20
17
15
12
11
11
11
10
9
9
8
8
8
7
7
7
7
7
7
7
6
6
5
5
5
5
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
220
89
30
20
13
9
6
Toolboxes
411
82
52
19
16
12
12
11
11
9
8
8
7
6
6
6
5
4
4
2
1
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause
...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-
...
The era of effective antibiotics is coming to a close. In just a few generations, many “miracle medicines”have been beaten into ineffectiveness by the bacteria they were intended to eradicate. Bacteria quickly adapt to the presence of antibacterial agents in order
...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect
...
(updated December 2014).
First report of a demonstration project
Annual Report: 2015-2016
(updated December 2014).
(updated December 2014).
Advocacy report March 2011
303100 03/2011 E 1,000
Policy and Manual
Epidemiology, Control, and Financing
